COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE

Aim. To compare direct medical costs of dabigatran and warfarin therapy in patients with non-valvular atrial fibrillation (NVAF) during preparation for elective cardioversion. Material and methods. An open non-randomized study was conducted to evaluate direct medical costs (cost of drug, cost of the...

Descrición completa

Detalles Bibliográficos

Principais autores:	L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky
Formato:	Artigo
Idioma:	Inglês
Publicado:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Assuntos:	atrial fibrillation cardioversion warfarin dabigatran costs rhythm control.
Acceso en liña:	https://www.rpcardio.online/jour/article/view/98
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!